Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $94.84 USD
Change Today +6.21 / 7.01%
Volume 464.4K
PBYI On Other Exchanges
New York
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas R. Malley CFA

Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee,Puma Biotechnology, Inc.
AgeTotal Calculated CompensationThis person is connected to 42 board members in 2 different organizations across 5 different industries.

See Board Relationships


Mr. Thomas R. Malley, CFA, served as the President of Mossrock Capital since May 2007. Mr. Malley served as Portfolio Manager and Securities Analyst at Janus Capital Management LLC. From 1991 to 1998, he served as an Equity Analyst for Janus covering healthcare and biotechnology, telecommunications, gaming and lodging, and housing stocks. From April 1991 to May 2007, he served in various roles at Janus Mutual Funds. He joined Janus Aspen Global in April 1991 as a Research ...

Read Full Background

Corporate Headquarters*

10880 Wilshire Boulevard
Los Angeles, California 90024

United States

Phone: 424-248-6500
Fax: 424-248-6501

Board Members Memberships*

Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Independent Director, Chairman of Compensation Committee and Member of Audit Committee


BS 1991
Stanford University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$50,000
Total Calculated Compensation$1,175,105
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBYI:US $94.84 USD +6.21


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PUMA BIOTECHNOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at